CVRx Inc Sustainability Reports
CVRx, Inc. is a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative neuromodulation solutions. Its core product, Barostim, is an implantable device designed to treat patients suffering from heart failure by activating the baroreflex mechanism.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001TJ3M57
2 reports from 2023 to 2024
Company Profile
CVRx, Inc. is a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative neuromodulation solutions. Its core product, Barostim, is an implantable device designed to treat patients suffering from heart failure by activating the baroreflex mechanism.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
